You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

36 search results for: itch

CSU is Associated With a High Burden and Impact on Quality of Life
expert video

CSU is Associated With a High Burden and Impact on Quality of Life

Dermatology
Dr. Casale discusses delays in diagnosing CSU, the impact of severe itch on daily life and mental health, and the challenges in achieving remission.
View more
The Burden of Chronic Spontaneous Urticaria: One Patient’s Journey to Diagnosis
videoanimation

The Burden of Chronic Spontaneous Urticaria: One Patient’s Journey to Diagnosis

Dermatology
Learn about the clinical presentation of CSU and the burden many CSU patients face by following one patient’s journey from symptom presentation to CSU diagnosis in this 5-minute video.
View more
Inside the Hive: ​Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
expert video

Inside the Hive: ​Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria

Dermatology
Join Dr. Jason Hawkes in discussing the burden of CSU and how type 2 inflammation contributes to the development of chronic wheals (hives) and angioedema
View more
ADVENT On Air | Exploring PN as a Distinct and Unique Disease
Podcast

ADVENT On Air | Exploring PN as a Distinct and Unique Disease

Dermatology
Dr. Sonja Ständer and Dr. Shawn Kwatra discuss the unique features of prurigo nodularis (PN) as well as the characteristics that are shared with atopic dermatitis, and aim to raise awareness of PN among both physicians and patients.
View more
ADVENT On Air - Dermatology
Podcast

ADVENT On Air | Expert Discussions in Dermatology

Dermatology
Listen to the latest updates in type 2 inflammatory science and associated skin diseases, brought to you by leading dermatology experts in the field. ADVENT On Air podcasts feature scientific conversations that explore new research into the pathophysiology, clinical features, and disease burden for a range of dermatological diseases linked to type 2 inflammation, including atopic dermatitis (AD) and prurigo nodularis (PN). Hear new insights revealed through expert-led conversations below or in your preferred podcast app.

View more
The Patient Burden of Chronic Pruritus of Unknown Origin (CPUO)
Infographic

The Patient Burden of Chronic Pruritus of Unknown Origin (CPUO)

Dermatology
An infographic describing the etiology, epidemiology, challenges in diagnosis and patient burden of CPUO.
View more
The Journey to Diagnosis: Considerations For AD, PN, and CSU
expert video

The Journey to Diagnosis: Considerations For AD, PN, and CSU

Dermatology
In this symposium from Fall Clinical 2023, join Drs. James Q. Del Rosso and Raj Chovatiya as they explore the journey to diagnosis of type 2 inflammation in AD, PN, and CSU.
View more
A Common Link: The Role of Type 2 Inflammation in the Clinical Presentation of AD, PN, and CSU
expert video

A Common Link: The Role of Type 2 Inflammation in the Clinical Presentation of AD, PN, and CSU

Dermatology
In this video from the ADVENT symposium at Fall Clinical 2023, join Dr. James Del Rosso as he explores the role of type 2 inflammation in the clinical presentation of AD, PN, and CSU.
View more
Connecting the Dots: Novel Insights on Type 2 Cytokines Mediating Neuroimmune Dysregulation in PN and CSU
expert video

Connecting the Dots: Novel Insights on Type 2 Cytokines Mediating Neuroimmune Dysregulation in PN and CSU

Dermatology
Dr. Kim discusses the roles of type 2 cytokines at the neuroimmune axis In PN and CSU and conveys how neuroimmune interactions give rise to chronic itch and skin lesions in each disease
View more
Type 2 Inflammation: A Common Link Between Atopic Dermatitis and Prurigo Nodularis
expert video

Type 2 Inflammation: A Common Link Between Atopic Dermatitis and Prurigo Nodularis

Dermatology
In this ADVENT symposium at the 2024 Diversity in Dermatology conference, Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on how clinical signs and itch in atopic dermatitis and prurigo nodularis are impacted by type 2 inflammation.
View more
Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice
expert video

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Dermatology
In this ADVENT symposium at the 2024 Diversity in Dermatology conference, experts Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on diagnostic considerations for atopic dermatitis and prurigo nodularis and how clinical signs and itch in these diseases are impacted by type 2 inflammation.
View more
The Burden of Disease in Atopic Dermatitis
expert video

The Burden of Disease in Atopic Dermatitis

Dermatology
Join Professor Simpson at FORUM II, where he provides an overview of the burden of disease in atopic dermatitis
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region